DREYX
Price
$43.26
Change
-$0.37 (-0.85%)
Updated
Feb 21 closing price
Net Assets
150.29M
VRTPX
Price
$22.02
Change
-$0.21 (-0.94%)
Updated
Feb 21 closing price
Net Assets
9.45B
Ad is loading...

DREYX vs VRTPX

Header iconDREYX vs VRTPX Comparison
Open Charts DREYX vs VRTPXBanner chart's image
Davis Real Estate Y
Price$43.26
Change-$0.37 (-0.85%)
VolumeN/A
Net Assets150.29M
Vanguard Real Estate II Index
Price$22.02
Change-$0.21 (-0.94%)
VolumeN/A
Net Assets9.45B
DREYX vs VRTPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DREYX vs. VRTPX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DREYX is a Buy and VRTPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.45B vs. DREYX (150M). VRTPX pays higher dividends than DREYX: VRTPX (3.98) vs DREYX (2.02). DREYX was incepted earlier than VRTPX: DREYX (28 years) vs VRTPX (7 years). DREYX has a lower initial minimum investment than VRTPX: DREYX (5000000) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 12.28 vs. DREYX (8.56). VRTPX return over 5 years is better than : 10.65 vs. DREYX (2.18).
DREYXVRTPXDREYX / VRTPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years7 years-
Gain YTD1.4062.80150%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets150M9.45B2%
Annual Yield % from dividends2.023.9851%
Returns for 1 year8.5612.2870%
Returns for 3 years-8.021.12-713%
Returns for 5 years2.1810.6521%
Returns for 10 years37.83N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPRO13.06-0.33
-2.46%
Expro Group Holdings NV
ADSE14.78-0.39
-2.57%
Ads-Tec Energy PLC
MTSI120.65-3.36
-2.71%
MACOM Technology Solutions Holdings
ATOS0.80-0.04
-5.32%
Atossa Therapeutics
RKDA3.98-0.41
-9.41%
Arcadia Biosciences